Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
about
Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized miceModeling the within-host dynamics of HIV infectionLost in Translation (LiT): IUPHAR Review 6Bone Marrow Gene Therapy for HIV/AIDSVery early combination antiretroviral therapy in infants: prospects for cureHIV-1 functional cure: will the dream come true?Dynamic models of viral replication and latencyDeveloping Combined HIV Vaccine Strategies for a Functional CureHost-pathogen interaction in HIV infectionMulti-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque ControllersHIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per CellMight dolutegravir be part of a functional cure for HIV?Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchPerspectives for immunotherapy: which applications might achieve an HIV functional cure?HIV treatment as prevention: contradictory perspectives from dynamic mathematical modelsClinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsetsHIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in InfectionHuman Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuarySocial and ethical implications of HIV cure researchMicrobiota and Probiotics in Health and HIV Infection.The potential of radioimmunotherapy as a new hope for HIV patients.Immunologic strategies for HIV-1 remission and eradication.Protein kinase D3 is essential for prostratin-activated transcription of integrated HIV-1 provirus promoter via NF-κB signaling pathwayLong-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cellsHIV-1 expression within resting CD4+ T cells after multiple doses of vorinostatChallenges in HIV Vaccine Research for Treatment and Prevention.Immune interventions in HIV infection.High IP-10 levels decrease T cell function in HIV-1-infected individuals on ARTChanges in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trialTissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells.Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activationA cross-sectional description of age and gender differences in exercise patterns in adults living with HIVDesigned transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllersComparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study.Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.The ethics of talking about 'HIV cure'Immuno-modulatory strategies for reduction of HIV reservoir cells.
P2860
Q21090483-CFE01D93-E688-4265-8DE5-00EF4F0B9E7CQ21245370-DD982BF3-8C1B-46BE-A696-0C9BD2C4FCE3Q24289150-A476B265-3200-43A5-857C-AFCF4EB20A9DQ26801765-BC7CF44D-4FA5-4053-94F6-FF52B61E91D1Q26830063-8ED875B9-04EB-4DF1-9367-663308DB8384Q26865803-F6C89B86-E69C-493C-9CCB-E30B6639E56EQ26866136-BFD43540-A221-4B9B-B679-01E81AC2EA6CQ26998898-73E6A7B8-86A2-4205-AC86-250A2AB2D609Q27009024-A3959557-F2FE-418C-917A-BFBAA032E8EBQ27312050-0516DA55-E6A3-4486-AF3B-493EDBA36D26Q27681313-120B5BA0-66B7-4E37-B8B3-8AEE414A32A7Q28071420-2679B796-7E49-44D3-8193-BE5BE63C60E3Q28077662-F63A8700-9336-48AA-A8EE-CDEE5E9D237FQ28078726-83427CAC-8698-46C9-A4CE-D86703C6A39FQ28080917-788BFE4F-DDD6-49F1-8DE8-7FB8561D82C8Q33591190-83008447-FBFC-4D05-AD4D-FDFBF3C83D03Q33629133-21389BAC-3E18-486B-B56B-0DB79F878470Q33742139-BC3E1491-EC5E-41ED-8ED8-C2A964B072E9Q33807288-4B78DD42-EA68-40E4-8CFC-C725FA14807EQ33852108-208AEBC7-8676-4E3B-AA01-74F8057F8303Q33863509-DC2156A8-E785-4C74-B77D-3C0D1EC61107Q33896523-836EDCC8-ACC9-4B2D-BCCE-E580A69B4D47Q34022422-C4F06AC9-24DB-4BDD-8FFF-AB6007A0DD2FQ34059612-7F1D1BA4-DE6F-4A7E-A0CE-A3C1F4BE9CB5Q34106191-5825445D-32F4-4235-B9E0-8EABBDD06674Q34148683-CBDF9F61-08E0-4D39-B676-53CE7C4FEACAQ34351326-9146C956-130C-4AE3-AC68-75747FDD34E0Q34484092-E74E8C16-0115-40DF-A29A-A8B79BEFC922Q34498678-FC145810-D505-4251-B157-1FE20D667A8BQ34513477-D740F930-BECC-4F9D-B100-3158FC7535DFQ34561884-C27DEDD5-7984-4CBF-AD25-503916C6DDF4Q34666498-8BADA876-1E2F-4EAB-AABD-AAD5777AB2D4Q34682171-98C3F9E5-12C6-42B6-A2ED-2425536C112AQ34824940-FF2E3C54-0985-4761-8AA3-B882EF966EBDQ34870253-720AFD2C-7090-4A96-9717-9962B73CCCD0Q35058635-852B35B1-E112-47CC-A3EB-55B718A9CCB9Q35109483-F42DAC57-0BBD-4419-B340-72B8834C1760Q35156765-BED72BA1-218C-4F5F-AFB9-483BE20C910DQ35226119-E4DACB95-4CCE-4177-A5EF-03E650657ED2Q35329923-D519982F-995D-45D3-BA9F-C98EB89B7D58
P2860
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
@en
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.
@nl
type
label
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
@en
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.
@nl
prefLabel
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
@en
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.
@nl
P2093
P2860
P50
P1433
P1476
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
@en
P2093
Douglas D Richman
Jeffrey Ahlers
Michael Miller
P2860
P304
P356
10.1016/S0140-6736(13)60104-X
P407
P50
P577
2013-03-29T00:00:00Z